NFE2L3 is highly expressed in Hodgkin’s lymphoma, pancreatic cancer, hepatocellular carcinoma, gastric cancer, colorectal cancer and other malignant tumours [31–37]. This evidence concerns the gene NFE2L3 and familial pancreatic carcinoma.